4.4 Article

One mutation, three phenotypes: novel metabolic insights on MELAS, MIDD and myopathy caused by the m.3243A > G mutation

Related references

Note: Only part of the references are listed.
Article Clinical Neurology

Exploring mTOR inhibition as treatment for mitochondrial disease

Abigail Sage-Schwaede et al.

ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2019)

Article Biochemistry & Molecular Biology

Normalizing Untargeted Periconceptional Urinary Metabolomics Data: A Comparison of Approaches

Ana K. Rosen Vollmar et al.

METABOLITES (2019)

Article Medicine, Research & Experimental

Metabolomes of mitochondrial diseases and inclusion body myositis patients: treatment targets and biomarkers

Jana Buzkova et al.

EMBO MOLECULAR MEDICINE (2018)

Review Cell Biology

Metabolomics of mitochondrial disease

Karien Esterhuizen et al.

MITOCHONDRION (2017)

Review Chemistry, Physical

Beyond the paradigm: Combining mass spectrometry and nuclear magnetic resonance for metabolomics

Darrell D. Marshall et al.

PROGRESS IN NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY (2017)

Article Biochemistry & Molecular Biology

Metabolomic Profiling of Human Urine as a Screen for Multiple Inborn Errors of Metabolism

Adam D. Kennedy et al.

GENETIC TESTING AND MOLECULAR BIOMARKERS (2016)

Article Multidisciplinary Sciences

The oncometabolite 2-hydroxyglutarate activates the mTOR signalling pathway

Melissa Carbonneau et al.

NATURE COMMUNICATIONS (2016)

Article Cell Biology

2-Hydroxyglutarate Inhibits ATP Synthase and mTOR Signaling

Xudong Fu et al.

CELL METABOLISM (2015)

Letter Clinical Neurology

Mitochondrial recessive ataxia syndrome: A neurological rarity not to be missed

Andrea Mignarri et al.

JOURNAL OF THE NEUROLOGICAL SCIENCES (2015)

Article Urology & Nephrology

The urinary proteome and metabonome differ from normal in adults with mitochondrial disease

Andrew M. Hall et al.

KIDNEY INTERNATIONAL (2015)

Review Endocrinology & Metabolism

MELAS syndrome: Clinical manifestations, pathogenesis, and treatment options

Ayman W. El-Hattab et al.

MOLECULAR GENETICS AND METABOLISM (2015)

Review Neurosciences

When should MERRF (myoclonus epilepsy associated with ragged-red fibers) be the diagnosis?

Paulo Jose Lorenzoni et al.

ARQUIVOS DE NEURO-PSIQUIATRIA (2014)

Review Biochemistry & Molecular Biology

Mitochondrial genome changes and neurodegenerative diseases

Milena Pinto et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2014)

Article Medicine, Research & Experimental

Effective treatment of mitochondrial myopathy by nicotinamide riboside, a vitamin B3

Nahid A. Khan et al.

EMBO MOLECULAR MEDICINE (2014)

Editorial Material Engineering, Environmental

Identifying Small Molecules via High Resolution Mass Spectrometry: Communicating Confidence

Emma L. Schymanski et al.

ENVIRONMENTAL SCIENCE & TECHNOLOGY (2014)

Review Clinical Neurology

A guide to diagnosis and treatment of Leigh syndrome

Fabian Baertling et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2014)

Article Cell Biology

Metabolic features of the cell danger response

Robert K. Naviaux

MITOCHONDRION (2014)

Article Multidisciplinary Sciences

The metabolite α-ketoglutarate extends lifespan by inhibiting ATP synthase and TOR

Randall M. Chin et al.

NATURE (2014)

Article Biochemistry & Molecular Biology

Potential metabolite markers of schizophrenia

J. Yang et al.

MOLECULAR PSYCHIATRY (2013)

Article Multidisciplinary Sciences

mTOR Inhibition Alleviates Mitochondrial Disease in a Mouse Model of Leigh Syndrome

Simon C. Johnson et al.

SCIENCE (2013)

Review Chemistry, Analytical

Modern analytical techniques in metabolomics analysis

Aihua Zhang et al.

ANALYST (2012)

Article Endocrinology & Metabolism

Metabolomics of urinary organic acids in respiratory chain deficiencies in children

Carolus J. Reinecke et al.

METABOLOMICS (2012)

Article

Protean Phenotypic Features of the A3243G Mitochondrial DNA Mutation

Petra Kaufmann et al.

ARCHIVES OF NEUROLOGY (2009)

Review Biochemistry & Molecular Biology

Mitochondrial Fatty Acid Synthesis Type II: More than Just Fatty Acids

J. Kalervo Hiltunen et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2009)

Editorial Material Endocrinology & Metabolism

Fatty acid oxidation and insulin action - When less is more

Deborah M. Muoio et al.

DIABETES (2008)

Article Cell Biology

Population prevalence of the MELAS A3243G mutation

Neil Manwaring et al.

MITOCHONDRION (2007)

Article Biochemistry & Molecular Biology

Endogenous production of lipoic acid is essential for mouse development

XW Yi et al.

MOLECULAR AND CELLULAR BIOLOGY (2005)

Article Biochemistry & Molecular Biology

Respiratory chain defects:: what do we know for sure about their consequences in vivo?

JJ Brière et al.

BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS (2004)

Review Biochemistry & Molecular Biology

Metabolomics - the link between genotypes and phenotypes

O Fiehn

PLANT MOLECULAR BIOLOGY (2002)